rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Brady Stewart

Director

Company insider

Files Form 4 as: Director, Evolus.

In numbers

Trades disclosed
10
Buys
1
Sells
0
Bought
$205K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
5 Jan 2022
Last trade
17 Feb 2026
Last filed
19 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
EOLS EvolusDirector · Biotechnology · last 17 Feb 20261 buy · 0 sells

Activity over time

1 Aug 2025 – 1 Oct 2026
01Aug 25Dec 25Mar 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Feb 2026filed 19 Feb 2026EOLS EvolusBiotechnologySEC FORM 4 Code A—45,559 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS EvolusBiotechnologySEC FORM 4 Code A—45,559 at $0.00filing
15 Aug 2025filed 18 Aug 2025EOLS EvolusBiotechnologySEC FORM 4 Bought$205K30,000 at $6.82filing
7 Mar 2025filed 11 Mar 2025EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—11,146 at $0.00filing
7 Mar 2025filed 11 Mar 2025EOLS EvolusBiotechnologySEC FORM 4 Code A—7,364 at $0.00filing
7 Feb 2024filed 9 Feb 2024EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—9,377 at $0.00filing
7 Feb 2024filed 9 Feb 2024EOLS EvolusBiotechnologySEC FORM 4 Code A—6,464 at $0.00filing
27 Jan 2023filed 31 Jan 2023EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—11,789 at $0.00filing
27 Jan 2023filed 31 Jan 2023EOLS EvolusBiotechnologySEC FORM 4 Code A—8,293 at $0.00filing
5 Jan 2022filed 7 Jan 2022EOLS EvolusBiotechnologySEC FORM 4 Code A—36,508 at $0.00filing

News

Lifecore Biomedical (NASDAQ:LFCR) vs. Evolus (NASDAQ:EOLS) Head to Head ComparisonEOLS · themarketsdaily.com · 14 Oct 2026Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonEOLS · dailypolitical.com · 13 Oct 2026

0 headlines in the last 90 days name Brady Stewart; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

David MoatazediDirector and Officer · Director and Officer at Evolus, filing Form 4 there in the last year
Rui AvelarOfficer · Officer at Evolus, filing Form 4 there in the last year
David N. GillDirector · Director at Evolus, filing Form 4 there in the last year
Vikram MalikDirector · Director at Evolus, filing Form 4 there in the last year
Tatjana MitchellChief Financial Officer · Chief Financial Officer at Evolus, filing Form 4 there in the last year